Literature DB >> 28152575

Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit.

Yaron Rotman1, Brent A Neuschwander-Tetri2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28152575      PMCID： PMC5360493          DOI： 10.1002/hep.29094

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  12 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

Authors:  Elisa Fabbrini; B Selma Mohammed; Faidon Magkos; Kevin M Korenblat; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

3.  Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels.

Authors:  Brent A Neuschwander-Tetri; Aynur Unalp; Michael H Creer
Journal:  Arch Intern Med       Date:  2008-03-24

4.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

5.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

6.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

Authors:  Anneli Seppälä-Lindroos; Satu Vehkavaara; Anna-Maija Häkkinen; Takashi Goto; Jukka Westerbacka; Anssi Sovijärvi; Juha Halavaara; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

7.  Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Authors:  Kevin M Korenblat; Elisa Fabbrini; B Selma Mohammed; Samuel Klein
Journal:  Gastroenterology       Date:  2008-01-30       Impact factor: 22.682

8.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

9.  Glycolipids and other lipid constituents of normal human liver.

Authors:  P O Kwiterovich; H R Sloan; D S Fredrickson
Journal:  J Lipid Res       Date:  1970-07       Impact factor: 5.922

10.  Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.

Authors:  Amalia Gastaldelli; Stephen A Harrison; Renata Belfort-Aguilar; Lou Jean Hardies; Bogdan Balas; Steven Schenker; Kenneth Cusi
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425
View more
  5 in total

1.  [Correlation between ectopic fat accumulation and insulin sensitivity in obese individuals with different glucose tolerance levels].

Authors:  Shui-Qing Lai; Zhen-Zhen Hong; Hong-Mei Chen; Jin-Xin Lin; Jian Kuang; Yan-Bing Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

Review 2.  Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

Authors:  Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

Review 3.  NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.

Authors:  Amélio F Godoy-Matos; Wellington S Silva Júnior; Cynthia M Valerio
Journal:  Diabetol Metab Syndr       Date:  2020-07-14       Impact factor: 3.320

Review 4.  Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.

Authors:  Adriana Fontes; Mireia Alemany-Pagès; Paulo J Oliveira; João Ramalho-Santos; Hans Zischka; Anabela Marisa Azul
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

Review 5.  Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns.

Authors:  Zuqing Su; Yutong Nie; Xiufang Huang; Ying Zhu; Bing Feng; Lipeng Tang; Guangjuan Zheng
Journal:  Front Pharmacol       Date:  2019-10-10       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.